Creo Medical Group "gaining a level of acceptance" in endoscopy Digital Asset Direct by Creo Medical Group PLC Download PDF Download multimedia London, UK | May 23, 2023 11:15 AM Eastern Daylight Time Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford speaks to Thomas Warner from Proactive about the latest developments at the medical device company, following a successful appearance at Digestive Disease Week. Gulliford says that Creo Medical is "gaining a level of acceptance" both within its home market the UK and beyond, highlighting increasing interest from the burgeoning Asian market. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com